Inhaled AMP induces a systemic inflammatory response in mild asthmatics

B. Luijk, C. van Aalst, L. Koenderman, J. W. J. Lammers (Utrecht, The Netherlands)

Source: Annual Congress 2003 - Clinical allergen and adenosine provocation to understand asthma
Session: Clinical allergen and adenosine provocation to understand asthma
Session type: Oral Presentation
Number: 2222
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Luijk, C. van Aalst, L. Koenderman, J. W. J. Lammers (Utrecht, The Netherlands). Inhaled AMP induces a systemic inflammatory response in mild asthmatics. Eur Respir J 2003; 22: Suppl. 45, 2222

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Short-term treatment with sistemic corticosteroids blunted neutrophilic airway response to ozone in mild asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 569s
Year: 2002

Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 135s
Year: 2005

Inhaled corticosteroids decrease exercise-induced inflammation in patients with COPD
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007


Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma
Source: Eur Respir J 2002; 19: 872-878
Year: 2002



Dose response for inhaled fluticasone on airway and systemic inflammation in COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009

Dose–response for inhaled fluticasone on airway and systemic inflammation in COPD
Source: Eur Respir J 2011; 37: 206-209
Year: 2011


Formoterol restores corticosteroid responses in corticosteroid-insensitive severe asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 50s
Year: 2005

Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 24s
Year: 2007

Inhaled budesonide suppresses airway and systemic eosinophilic inflammation in COPD. No predictive value of a prednisolone test treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005

Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 309s
Year: 2002

Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007


Relationships of mannitol challenge to methacholine challenge and inflammatory markers in asthmatics receiving inhaled corticosteroids
Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease
Year: 2012



The airway inflammatory response in allergic mice is downregulated by budesonide
Source: Eur Respir J 2001; 18: Suppl. 33, 265s
Year: 2001

Inhaled racemic salbutamol may cause enhanced bronchial response to cold air in mild asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 105s
Year: 2001

Interleukin-2 inhalation therapy temporarily induces asthma-like functional changes and airway inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 479s
Year: 2003

Changes in airway inflammation, remodelling and PD20 following inhaled corticosteroid treatment are not temporally concordant
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001

Inhaled insulin does not trigger lung inflammation and airway remodelling
Source: Eur Respir J 2009; 33: 444-445
Year: 2009


An inhaled IGFBP-3 peptide attenuates steroid-resistant neutrophilic bronchial asthma through modulation of ER stress
Source: International Congress 2019 – Novel targets and mechanisms in asthma
Year: 2019




Oral presentation: Sphingosine-1-phosphate administration in vivo induces airway inflammation and hypereactivity in a IgE-dependent manner
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013


Effects of roflumilast on exhaled NO, airway hyperresponsiveness, and inflammatory markers in patients with asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 670s
Year: 2006